A study in humans identified hsa-miR-513c-5p as a component of a competing endogenous RNA network, where it was upregulated in plasma samples from patients with hypertrophic cardiomyopathy and was predicted to target key diagnostic genes [Yu et al. DOI:10.1186/s40659-023-00451-4].